Bansisons Tea Industries Ltd — Important, 30-05-2026: Company Update
30-05-2026 | 12:37 pm
30-05-2026 | 12:37 pm
Novyra Pharmachem has affirmed that funds totaling Rs. 13.245 lakh, raised through a preferential issue, were fully used for their intended working capital needs, with no reported deviations. The company's total paid-up equity share capital is Rs. 6.33 Cr, divided into 63.30 lakh shares of Rs. 10 each. Previously, the Board converted 1.766 lakh partly paid shares, leading to all issued shares now being fully paid. This update highlights sound financial management and transparency in capital utilization, providing clarity on the company's financial structure for shareholders.
No comments yet. Be the first to comment!
